Endoktak Lead System
FDA premarket approval P910073/S167 · decided 2021-10-06
Approval details
- PMA number
- P910073
- Supplement
- S167
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- Endoktak Lead System
- Generic name
- Implantable cardioverter defibrillator (non-CRT)
- Applicant
- Boston Scientific
- Date received
- 2021-09-30
- Decision date
- 2021-10-06
- Days to decision
- 6 days
- Decision code
- OK30
- Product code
- LWS
- Advisory committee
- Cardiovascular
- Expedited review
- No
- Location
- St Paul, MN
- Statement
- Add an alternate thermal transfer ribbon for improved legibility for use in the Dorado, Puerto Rico facility.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.